Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ZIVO Bioscience, Inc. (ZIVO : NSDQ)

• Company Description    Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan. Number of Employees: 10

• Price / Volume Information    Yesterday's Closing Price: $2.94 Daily Weekly Monthly 20 Day Moving Average: 6,256 shares Shares Outstanding: 9.42 (millions) Market Capitalization: $27.69 (millions) Beta: 0.15 52 Week High: $12.00 52 Week Low: $2.37 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -17.18% -9.26% 12 Week -19.45% -12.60% Year To Date 2.44% 21.82%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 21 EAST LONG LAKE ROAD SUITE 100 - BLOOMFIELD HILLS,MI 48304 USA ph: 248-452-9866 fax: - tpatel@lhai.com http://www.zivobioscience.com

• General Corporate Information    Officers John B. Payne - Chief Executive Officer; President Keith R. Marchiando - Chief Financial Officer; and Secretary Christopher D. Maggiore - Director Nola E. Masterson - Director Alison A. Cornell - Director Peer Information ZIVO Bioscience, Inc. (CORR.) ZIVO Bioscience, Inc. (RSPI) ZIVO Bioscience, Inc. (CGXP) ZIVO Bioscience, Inc. (BGEN) ZIVO Bioscience, Inc. (GTBP) ZIVO Bioscience, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 98978N200 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/21 Next Expected EPS Date: 05/16/22 Share - Related Items Shares Outstanding: 9.42 Most Recent Split Date: 5.00 (0.01:1) Beta: 0.15 Market Capitalization: $27.69 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/16/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.04 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 73.75% vs. Previous Quarter: 25.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -144.91 12/31/21 - -391.40 09/30/21 - - ROA 03/31/22 - -96.22 12/31/21 - -119.98 09/30/21 - -137.58 Current Ratio 03/31/22 - 2.52 12/31/21 - 3.04 09/30/21 - 3.42 Quick Ratio 03/31/22 - - 12/31/21 - 3.04 09/30/21 - 3.08 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 0.49 12/31/21 - 0.64 09/30/21 - 0.84 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©